Clinical trial

Effectiveness of Two Approved Drugs in Lowering High Cholesterol (0733-224)

NCT00092157 · Organon and Co, Industry · Completed

Key facts

NCT number NCT00092157
Title Effectiveness of Two Approved Drugs in Lowering High Cholesterol (0733-224)
Official title A Multicenter, Randomized, Double-Blind, Parallel Group Study to Evaluate the Tolerability and Efficacy of the Co-Administration of Simvastatin 20 mg/Day and Fenofibrate 160 mg/Day Compared to Simvastatin 20 mg/Day Alone for 12 Weeks of Treatment in Patients With Combined Hyperlipidemia-Simvastatin…
Lead sponsor Organon and Co, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Hypercholesterolemia
Intervention type Drug
Interventions MK0733, simvastatin, Comparator: simvastatin
Enrollment 571
Start date May 1, 2002
Primary completion Mar 3, 2003
Completion Mar 4, 2003
First posted Sep 24, 2004
Last update posted Aug 15, 2024

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies